Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ikena Oncology (IKNA) just unveiled an update.
Ikena Oncology, Inc. has elevated Jotin Marango, M.D., Ph.D. to the role of Chief Operating Officer while he retains his positions as Chief Financial Officer and Head of Corporate Development. Dr. Marango brings a wealth of experience from previous high-level roles in biotech firms and equity research, with a strong background in oncology. His promotion includes a salary increase to $470,000 and an option for 400,000 shares, contingent on a strategic company transaction and ongoing service. Dr. Marango’s appointment is based solely on his professional qualifications, with no familial ties to the company’s leadership.
See more insights into IKNA stock on TipRanks’ Stock Analysis page.